BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10084692)

  • 1. Monomorphic HLA class I-(non-A, non-B) expression on Ewing's tumor cell lines, modulation by TNF-alpha and IFN-gamma.
    Borowski A; van Valen F; Ulbrecht M; Weiss EH; Blasczyk R; Jürgens H; Göbel U; Schneider EM
    Immunobiology; 1999 Feb; 200(1):1-20. PubMed ID: 10084692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential modulation by tumor necrosis factor and immune interferon of HLA class-II antigens expressed by melanoma cells.
    Maio M; Gulwani B; Morgano A; Ferrone S
    Int J Cancer; 1989 Sep; 44(3):554-9. PubMed ID: 2506138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-class-I and -class-II expression on renal tumor xenografts and the relation to sensitivity for alpha-IFN, gamma-IFN and TNF.
    Beniers AJ; Peelen WP; Debruyne FM; Schalken JA
    Int J Cancer; 1991 Jul; 48(5):709-16. PubMed ID: 1906431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine regulation of HLA-G expression in human trophoblast cell lines.
    Yang Y; Geraghty DE; Hunt JS
    J Reprod Immunol; 1995 Oct; 29(3):179-95. PubMed ID: 8636924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of gamma interferon on HLA class-I and -II transcription and protein expression in human breast adenocarcinoma cell lines.
    Jabrane-Ferrat N; Faille A; Loiseau P; Poirier O; Charron D; Calvo F
    Int J Cancer; 1990 Jun; 45(6):1169-76. PubMed ID: 2112515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of interferon-gamma and tumor necrosis factor on the expression of class I and class II major histocompatibility molecules by cultured human umbilical vein endothelial cells.
    Wedgwood JF; Hatam L; Bonagura VR
    Cell Immunol; 1988 Jan; 111(1):1-9. PubMed ID: 3123068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EWS/FLI-l peptide-pulsed dendritic cells induces the antitumor immunity in a murine Ewing's sarcoma cell model.
    Peng W; Huang X; Yang D
    Int Immunopharmacol; 2014 Aug; 21(2):336-41. PubMed ID: 24861249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High frequency of altered HLA class I phenotypes in laryngeal carcinomas.
    Cabrera T; Salinero J; Fernandez MA; Garrido A; Esquivias J; Garrido F
    Hum Immunol; 2000 May; 61(5):499-506. PubMed ID: 10773352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined treatment with interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha up-regulates the expression of HLA class I determinants in Burkitt lymphoma lines.
    Avila-Carino J; Torsteinsdottir S; Bejarano MT; Klein G; Klein E; Masucci MG
    Cell Immunol; 1988 Dec; 117(2):303-11. PubMed ID: 2848629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
    Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
    Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of MHC-class-I alterations in human tumor cell lines.
    Ruiz-Cabello F; Perez-Ayala M; Gomez O; Redondo M; Concha A; Cabrera T; Garrido F
    Int J Cancer Suppl; 1991; 6():123-30. PubMed ID: 1906050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of interferon induction of class I major histocompatibility complex antigen expression by human tumor necrosis factor in small cell lung cancer cell lines.
    Marley GM; Doyle LA; Ordóñez JV; Sisk A; Hussain A; Yen RW
    Cancer Res; 1989 Nov; 49(22):6232-6. PubMed ID: 2553249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced human leukocyte antigen expression in advanced-stage Ewing sarcoma: implications for immune recognition.
    Berghuis D; de Hooge AS; Santos SJ; Horst D; Wiertz EJ; van Eggermond MC; van den Elsen PJ; Taminiau AH; Ottaviano L; Schaefer KL; Dirksen U; Hooijberg E; Mulder A; Melief CJ; Egeler RM; Schilham MW; Jordanova ES; Hogendoorn PC; Lankester AC
    J Pathol; 2009 Jun; 218(2):222-31. PubMed ID: 19274709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of HLA-DR gene expression induced by IFN-gamma in malignant melanoma cell lines.
    Lee JL; Kim YH; Lee JM; Kim JD; Kim SJ; Park JH
    Yonsei Med J; 1999 Feb; 40(1):30-9. PubMed ID: 10198604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stable transgenic expression of IL-2 and HSV1-tk by single and fusion tumor cell lines bearing EWS/FLI-1 chimeric genes.
    Staege MS; Gorelov V; Bulankin A; Fischer U; Dumon K; Hohndorf L; Hattenhorst U; Kramm C; Burdach S
    Pediatr Hematol Oncol; 2003 Mar; 20(2):119-40. PubMed ID: 12554523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-F is a predominantly empty, intracellular, TAP-associated MHC class Ib protein with a restricted expression pattern.
    Wainwright SD; Biro PA; Holmes CH
    J Immunol; 2000 Jan; 164(1):319-28. PubMed ID: 10605026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine (IFN-alpha, IFN-gamma, IL-1-alpha, TNF-alpha)-induced modulation of HLA cell surface expression in human breast cancer cell lines.
    Sedlák J; Speiser P; Zeillinger R; Krugluger W; Wiltschke C; Kubista E; Chorváth B
    Neoplasma; 1992; 39(5):269-72. PubMed ID: 1436241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of HLA-class I antigens in human neuroblastoma cells: analysis of its relationship to TAP and tapasin expression.
    Corrias MV; Occhino M; Croce M; De Ambrosis A; Pistillo MP; Bocca P; Pistoia V; Ferrini S
    Tissue Antigens; 2001 Feb; 57(2):110-7. PubMed ID: 11260505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of HLA-E expression in human tumors.
    Marín R; Ruiz-Cabello F; Pedrinaci S; Méndez R; Jiménez P; Geraghty DE; Garrido F
    Immunogenetics; 2003 Feb; 54(11):767-75. PubMed ID: 12618909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of HLA class I molecules expression on tumor cell resistance to NK lysis and the IFN-gamma regulatory effect].
    Zhang C; Tian Z; Hou G
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):369-72. PubMed ID: 11810763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.